Related Experiment Video
Updated: Jun 6, 2026

A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
Published on: July 20, 2017
Slit2/Robo1 signaling in glioma migration and invasion
1Central Laboratory of Oncology Department, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Breast Cancer Prevention and Therapy of the Ministry of Education, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin 300060, China.
Abstract:
Slit2/Robo1 is a conserved ligand-receptor system, which greatly affects the distribution, migration, axon guidance and branching of neuron cells. Slit2 and its transmembrane receptor Robo1 have different distribution patterns in gliomas. The expression of Slit2 is at very low levels in pilocytic astrocytoma, fibrillary astrocytoma and glioblastoma, while Robo1 is highly expressed in different grades of gliomas at both mRNA and protein levels. Acquisition of insidious invasiveness by malignant glioma cells involves multiple genetic alterations in signaling pathways. Although the specific mechanisms of tumor-suppressive effect of Slit2/Robo1 have not been elucidated, it has been proved that Slit2/Robo1 signaling inhibits glioma cell migration and invasion by inactivation of Cdc42-GTP. With the research development on the molecular mechanisms of Slit2/Robo1 signaling in glioma invasion and migration, Slit2/Robo1 signaling may become a potential target for glioma prevention and treatment.
Insights
The Slit2/Robo1 pathway, crucial for neuron development, shows low Slit2 and high Robo1 expression in gliomas. This signaling pathway inhibits glioma cell invasion, suggesting potential therapeutic applications.
Area of Science:
- Neuroscience
- Oncology
Background:
- The Slit2/Robo1 ligand-receptor system regulates neuronal development, including cell migration and axon guidance.
- Aberrant expression of Slit2 and Robo1 is observed in various glioma grades, with low Slit2 and high Robo1 levels.
- Glioma cell invasiveness is linked to genetic alterations in signaling pathways.
Purpose of the Study:
- To investigate the role of the Slit2/Robo1 signaling pathway in glioma cell migration and invasion.
- To explore the potential of Slit2/Robo1 as a therapeutic target for glioma.
Main Methods:
- Analysis of Slit2 and Robo1 expression patterns in different glioma grades at mRNA and protein levels.
- Investigation of Slit2/Robo1 signaling's effect on glioma cell migration and invasion.
- Examination of the molecular mechanisms, including Cdc42-GTP inactivation, underlying Slit2/Robo1's tumor-suppressive effects.
Main Results:
- Slit2 expression is significantly low in pilocytic astrocytoma, fibrillary astrocytoma, and glioblastoma.
- Robo1 is highly expressed across different glioma grades at both mRNA and protein levels.
- Slit2/Robo1 signaling was demonstrated to inhibit glioma cell migration and invasion, partly through Cdc42-GTP inactivation.
Conclusions:
- The Slit2/Robo1 pathway exhibits tumor-suppressive properties in gliomas by inhibiting cell migration and invasion.
- Understanding the molecular mechanisms of Slit2/Robo1 signaling in glioma is crucial.
- Slit2/Robo1 signaling represents a promising therapeutic target for glioma prevention and treatment.
Related Concept Videos
Cell Polarization by Rho Proteins
Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

